| RS886043626 |
USH1G
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS886043627 |
TUBA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Tubulinopathy |
| RS886043629 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS886043630 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS886043631 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS886043634 |
SHOX
|
Health Risk |
Conflicting classifications of pathogenicity |
SHOX-related short stature, SHOX-related short stature |
| RS886043635 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043636 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS886043639 |
DDX3X
|
Health Risk |
Likely pathogenic |
— |
| RS886043640 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Cardiomyopathy |
| RS886043641 |
COL5A1
|
Health Risk |
Pathogenic |
— |
| RS886043644 |
UNC80
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043645 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS886043648 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS886043654 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS886043657 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS886043663 |
KLHL7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043669 |
GP6
|
Health Risk |
Pathogenic |
— |
| RS886043676 |
DMD
|
Health Risk |
Pathogenic |
Motor delay, Calf muscle hypertrophy |
| RS886043677 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS886043680 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886043681 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS886043685 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043686 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS886043692 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS886043694 |
CUL4B
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS886043699 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043700 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043703 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS886043704 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brittle cornea syndrome 1 |
| RS886043705 |
CAPN3
|
Health Risk |
Pathogenic |
— |
| RS886043706 |
FKRP
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS886043708 |
HSD17B4
|
Health Risk |
Pathogenic |
— |
| RS886043709 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS886043710 |
MATN3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043711 |
BMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature, facial dysmorphism |
| RS886043712 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS886043713 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043715 |
FLVCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043716 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS886043718 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS886043725 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS886043728 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS886043734 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS886043737 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043741 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS886043742 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS886043743 |
THRB
|
Health Risk |
Pathogenic |
— |
| RS886043744 |
NPC1
|
Health Risk |
Likely pathogenic |
— |
| RS886043745 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS886043749 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS886043750 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886043751 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, UMOD-related disorder |
| RS886043752 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886043753 |
RETREG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS886043756 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Inborn genetic diseases |
| RS886043764 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043769 |
KCNJ13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043772 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043773 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2S, Autosomal recessive distal spinal muscular atrophy 1 |
| RS886043774 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS886043776 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS886043780 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS886043784 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS886043786 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome type 6, Joubert syndrome 17 |
| RS886043789 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043790 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS886043792 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS886043793 |
OTX2
|
Health Risk |
Pathogenic |
— |
| RS886043794 |
COL2A1
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia, Beighton type |
| RS886043796 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS886043797 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS886043802 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS886043805 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043807 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS886043809 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS886043810 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS886043812 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS886043813 |
HNF1B
|
Health Risk |
Likely pathogenic |
Renal cysts and diabetes syndrome, Type 2 diabetes mellitus |
| RS886043817 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886043822 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043826 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS886043831 |
SOX9
|
Health Risk |
Pathogenic |
— |
| RS886043833 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS886043839 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Inborn genetic diseases |
| RS886043840 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS886043841 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS886043844 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS886043848 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS886043851 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS886043852 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043854 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS886043860 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS886043864 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS886043866 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS886043869 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886043870 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type A |
| RS886043871 |
NPC1
|
Health Risk |
Pathogenic |
— |
| RS886043872 |
CUL7
|
Health Risk |
Pathogenic |
— |
| RS886043875 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |